Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
In this study, the investigators aim to compare the progression-free survival (PFS) and side
effects of radiotherapy (RT) and concurrent chemoradiotherapy (CCRT) in locoregionally
advanced nasopharyngeal carcinoma (NPC) patients with a satisfactory tumor response (complete
response or partial response) after neoadjuvant chemotherapy (NACT).
Phase:
Phase 3
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Collaborators:
First Affiliated Hospital of Wenzhou Medical University Jinhua Central Hospital Ningbo Medical Center Lihuili Eastern Hospital People's Hospital of Quzhou Quzhou People’s Hospital The Central Hospital of Lishui City Zhejiang Provincial People's Hospital Zhejiang Provincial People’s Hospital